PALO ALTO, Calif.--(BUSINESS WIRE)--Valar Labs, the developer of computational histology AI tests for predicting response to cancer therapies, announced new data today which is being presented on ...
Birmingham researchers funded by Cancer Research UK and liquid biopsy company Nonacus have developed a new urine test for bladder cancer, which could reduce the need for invasive and time-consuming ...
Valar Labs’ Vesta Bladder Risk Stratify Dx has secured breakthrough device designation from the US Food and Drug Administration (FDA), becoming the first artificial intelligence (AI)-based digital ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data that reinforce the ability of its Decipher Bladder Genomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results